Dr. Stephanie Venn-Watson is the CEO of Seraphina Therapeutics. A seasoned veterinary
epidemiologist and public health scientist, Stephanie previously served at the World Health
Organization and U.S. Navy. With a life-long mission of helping people (and our fellow animals)
age better, Stephanie’s award-winning approach to improving human and animal health has
been featured on NPR, BBC, CBS, and National Geographic. In her time as CEO, Seraphina
Therapeutics has been recognized for its extensive research and education on pentadecanoic
acid (C15:0)

Stephanie received her B.S. in Animal Physiology and Neuroscience from UC San Diego,
D.V.M. from Tufts University, M.P.H. from Emory University, and was a National Research
Council Associate with the Armed Forces Medical Intelligence Center. She is an Albert
Schweitzer Fellow for Life.